Samrat Pharmachem Ltd - Financial Result for the Quarter ended 30th Jun'26 (Standalone, INR Lakh)
Samrat Pharmachem Ltd · Outcome · 15 Aug 2026, 1:44 am
Samrat Pharmachem Ltd - Financial Result for the Quarter ended 30th Jun'26 (Standalone, INR Lakh) ■ Revenue: 7,976 (+5.4% YoY | +11.1% QoQ) ■ EBITDA: 89.9 (+622.6% YoY | Loss to Profit QoQ) ■ EBITDA Margin (%): 1.1 (+96 bps YoY | Loss to Profit QoQ) ■ PAT: 87.6 (Loss to Profit YoY | Loss to Profit QoQ) ■ EPS (INR): 2.84 (Loss to Profit YoY | Loss to Profit QoQ)
Original exchange filing (PDF)
More announcements from Samrat Pharmachem Ltd
- The Board of Directors considered and adopted the unaudited financial results for the quarter ended September 30, 2026 · 14 Nov 2026
- Samrat Pharmachem Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Samrat Pharmachem Limited .... · 14 Nov 2026
- The share holders of the company at the 34th AGM held on 23-09-2026, have approved the appointment of M/s. Divyesh J Shah & Associates, Chartered Accountants as Statutory Auditors of the .... · 24 Sept 2026
- Scrutinizer''s Report & Voting Results for 34th AGM · 24 Sept 2026
- The Company''s 34th AGM was held on 23rd September 2026 and the business mentioned in the prior notice was transacted. · 23 Sept 2026
- 34th Annual General Meeting of the company will be held on Wednesday, September 23, 2026 at 1:00 PM (IST) through Video Conferencing (VC) / Other Audio Video Means (OAVM) · 28 Aug 2026
- 34th Annual Report for the Financial Year 2025-26 · 28 Aug 2026
- Appointment of Statutory Auditors for the company from 34th Annual General Meeting to 39th Annual General Meeting · 17 Jul 2026
